要查看或添加评论,请登录
Clear Scientific, Inc的更多文章
-
2024年6月28日
Clear Scientific featured in latest issue of Eureka: A Dose of Science sponsored by Charles River Laboratories.
Cambridge MA | June 2024 Clear Scientific is featured in the June 24, 2024 issue of Eureka: A Dose of Science, a…
15
-
2024年5月22日
Clear Scientific is featured in the latest podcast episode of Vital Science sponsored by Charles River Laboratories
Cambridge, MA | May 22, 2024 Clear Scientific is featured in the latest episode of Vital Science, a podcast unveiling…
19
-
2024年4月10日
CS Inc. presents at 2024 Rx and Illicit Drug Summit
Atlanta, GA | April 1, 2024 Clear Scientific presented a poster titled: Hope in Methamphetamine Addiction and Overdose,…
5
-
2023年11月3日
Clear Scientific Awarded up to $15M from NIDA for Continued Development of Fentanyl Antidote
Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced an award from…
20
-
2023年11月3日
Clear Scientific Awarded $12M NIDA Grant for Continued Development of Meth Antidote.
Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced a $12M award…
10
1 条评论 -
2023年10月30日
Clear Scientific to Start Phase 1 Trial for Stimulant Antidote
October 30, 2023 Clear Scientific Inc., a Cambridge MA based biopharmaceutical company, announced that the FDA has…
19
3 条评论 -
2023年10月13日
Spotlight on CS-1103 during the Mitigating Risks from Human Xylazine Exposure Meeting sponsored by the Reagan-Udall Foundation for the FDA
Clear Scientific's antidote CS-1103 was featured in Medline Today highlighting its use against the dangerous and deadly…
7
-
2023年8月28日
Clear Scientific participates in NIDA/Babson College L-SPRINT program on Substance Use Disorder
On August 17th 2023 Winston Henderson, General Counsel of Clear Scientific Inc., participated as a panelist in…
9
-
2023年6月30日
CS Inc. presents at 85th Annual Scientific Meeting of the College on Problems of Drug Dependence.
Clear Scientific presented a poster titled: A Novel Approach to Treat Fentanyl Intoxication, Authors: X. Li, P.
4
-
2023年5月31日
CS Inc. antidote featured in Charles River Lab's Eureka Blog: Drug Modality Game Changers
Clear Scientific's CS 1103 antidote was featured in Charles River Laboratories Eureka Blog : Drug Modality Game…
5
社区洞察
-
Outside SalesHow can you address client concerns about new drug side effects?
-
Case ManagementHow can you integrate drug screening test data for case management?
-
StatisticsHow do you distinguish between a placebo and an active treatment?
-
Healthcare Information Technology (HIT)How do you collaborate and communicate with other stakeholders and organizations using RxNorm?
-
Chemical EngineeringWhat is the best way to predict the pharmacokinetics of a drug?
-
Market AccessHow can stakeholders collaborate and align incentives to facilitate innovative payment models for drugs?
-
Healthcare ManagementHow do you use utilization management metrics to monitor prescription drug use?
-
InterviewingWhat strategies can you use to work with complex drug development processes during an interview?
-
Analytical Methods DevelopmentHow do you handle method transfer and comparability studies?
-
Market AccessWhat are the potential risks and challenges of patient access schemes for drug development and innovation?
其他会员也浏览了
-
Nitazene Analogs
Aegis Sciences Corporation 1 年 -
The Legal Battle Over Nexium: Understanding the Lawsuits and Settlements
LezDo Medical Record Reviews 1 年 -
An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty
Daniel Levine 2 年 -
Drug Shortages in US
Girish Malhotra 1 年 -
How ICER Deals With the Reality That Drug Prices Are Not Skyrocketing
Brian Reid 3 年 -
A brief history of the launch of one (the first?) Anti-TNF agent Ex-US
Carlos Stalgis 6 年 -
Examining the Legislative Landscape for Rare Disease Drug Development
Daniel Levine 2 年 -
Pelosi drug bill will save money, but at what long-term cost?
Dana P Goldman 5 年 -
Think gas prices are high? Have you checked out the costs of new drug treatments recently?
Chris Heye, PhD 2 年